Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform

por Ramot, Yuval, Kronfeld, Noam, Ophir, Yakir, Ezov, Nati, Friedman, Sheli, Saloheimo, Markku, Vitikainen, Marika, Ben-Artzi, Hanna, Avigdor, Avi, Tchelet, Ronen, Valbuena Crespo, Noelia, Emalfarb, Mark, Nyska, Abraham
Publicado 2022